Cargando…

Percutaneous treatment of spontaneous left main coronary artery dissection using drug-eluting stent

BACKGROUND: Spontaneous coronary artery dissection is a rare cause of ischemic heart disease and sudden death. Prompt diagnosis is of paramount importance, especially in cases when it manifests with ST elevation myocardial infarction (STEMI). CASE PRESENTATION: We report a case of a 42 year-old woma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graidis, Christos, Dimitriadis, Dimokritos, Karasavvidis, Vasileios, Dimitriadis, Georgios, Argyropoulou, Efstathia, Economou, Fotios, Spiromitros, George, Antoniou, Antonios, Karakostas, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279601/ https://www.ncbi.nlm.nih.gov/pubmed/25519008 http://dx.doi.org/10.1186/1471-2261-14-191

Ejemplares similares

Prevalence and characteristics of coronary artery anomalies in an adult population undergoing multidetector-row computed tomography for the evaluation of coronary artery disease
por: Graidis, Christos, et al.
Publicado: (2015)

Acute presentation of vasospastic angina induced by oral capecitabine: a case report
por: Golias, Christos, et al.
Publicado: (2014)

Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
por: Panoulas, Vasileios F, et al.
Publicado: (2015)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2016)

Incidental Detection of Preputial Calculus in a Patient with Partial Phimosis: Is it as Rare as We Believed?
por: Symeonidis, Evangelos N., et al.
Publicado: (2021)

A comprehensive narrative review of residual curvature correction during penile prosthesis implantation in patients with severe erectile dysfunction and concomitant Peyronie’s disease
por: Sokolakis, Ioannis, et al.
Publicado: (2021)

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials
por: Alazzoni, Ashraf, et al.
Publicado: (2012)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Intravascular Ultrasound-Guided Percutaneous Coronary Intervention with Drug-eluting Stent for Unprotected Left Main Disease via Left Snuffbox Approach
por: Kim, Yongcheol, et al.
Publicado: (2018)

Commentary on: “Human umbilical cord wharton's jelly-derived mesenchymal stem cell transplantation could improve diabetic intracavernosal pressure”
por: Dimitriadis, Fotios, et al.
Publicado: (2021)

Endovascular Treatment of Infrarenal Isolated Abdominal Aortic Dissection with Application of the Kissing Stents Technique: A Case Report and Review of the Literature
por: Sahsamanis, Georgios, et al.
Publicado: (2017)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

The effect of standard percutaneous nephrolithotomy, miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery on biomarkers of renal injury: a randomized clinical trial
por: Memmos, Dimitrios, et al.
Publicado: (2023)

Drug‐Eluting Stents or Bypass Surgery for Left Main Disease: The Impact of Diabetes Mellitus
por: Ziada, Khaled M., et al.
Publicado: (2020)

Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis
por: Meng, Min, et al.
Publicado: (2016)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

Estrogen-Eluting Stents
por: Ryu, Sung Kee, et al.
Publicado: (2009)

Catheter Left Main Dissection Bailout Treatment with Stenting
por: Çitaku, Hajdin, et al.
Publicado: (2019)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Head-to-Head Comparison of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies
por: Zhang, Xinlin, et al.
Publicado: (2014)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
por: Wiemer, Marcus, et al.
Publicado: (2017)

Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
por: Baschet, Louise, et al.
Publicado: (2016)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Comparison of Bypass Surgery with Drug-Eluting Stents in Diabetic Patients with Left Main Coronary Stenosis
por: Zhao, Xiaoxiao, et al.
Publicado: (2011)

Five-year clinical outcomes following drug-eluting stent implantation in left main trifurcations
por: Gil, Robert J., et al.
Publicado: (2019)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Risk of non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents
por: Park, Sun-Kyung, et al.
Publicado: (2017)

Newer-Generation Drug-Eluting Stents in Patients Undergoing Complex Percutaneous Coronary Intervention
por: Otsuka, Kenichiro
Publicado: (2021)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
por: Zbinden, Rainer, et al.
Publicado: (2016)

Incidental giant renal oncocytoma: a case report
por: Anastasiadis, Anastasios, et al.
Publicado: (2010)

Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
por: Wiemer, Marcus, et al.
Publicado: (2017)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Effect of testosterone replacement treatment on constitutional and sexual symptoms in type 2 diabetic men: need for rules
por: Dimitriadis, Fotios, et al.
Publicado: (2015)

Impact of stent edge dissection detected by optical coherence tomography after current-generation drug-eluting stent implantation
por: Jinnouchi, Hiroyuki, et al.
Publicado: (2021)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Antibiotic eluting sinus stents
por: Thompson, Harrison M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dcd3st8h5iqbb5f5edlllv7anc